University Of Oxford
Clinical trials sponsored by University Of Oxford, explained in plain language.
-
Double vaccine attack on malaria shows promise in early trial
⭐️ VACCINE ⭐️ CompletedThis study tested two different malaria vaccines—one targeting the blood stage and one the liver stage—alone and in combination. 107 healthy adults and infants in The Gambia received the vaccines to check safety and immune response. The goal is to see if combining them offers bet…
Phase: PHASE1 • Sponsor: University of Oxford • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:31 UTC
-
New malaria vaccine passes early safety test in kids
⭐️ VACCINE ⭐️ CompletedThis study tested the R21/Matrix-M malaria vaccine in 594 children aged 5 to 36 months in Mali. Researchers checked if the vaccine is safe and triggers an immune response, both when given alone and alongside routine childhood vaccines like measles and yellow fever. The goal is to…
Phase: PHASE1 • Sponsor: University of Oxford • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:06 UTC
-
Major trial launches for oxford COVID-19 vaccine
⭐️ VACCINE ⭐️ CompletedThis large study tested the Oxford-AstraZeneca COVID-19 vaccine (ChAdOx1 nCoV-19) in over 10,000 healthy UK adults aged 18 and older. The goal was to see if the vaccine safely prevents symptomatic COVID-19. Participants received either the vaccine or a control shot, and researche…
Phase: PHASE2, PHASE3 • Sponsor: University of Oxford • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 26, 2026 12:32 UTC
-
Oxford COVID-19 vaccine shows promise in early trial
⭐️ VACCINE ⭐️ CompletedThis study tested a new COVID-19 vaccine called ChAdOx1 nCoV-19 in over 1,000 healthy adults aged 18-55 in the UK. The goal was to see if the vaccine is safe, triggers an immune response, and can prevent COVID-19. Participants received either the vaccine or a comparison shot, and…
Phase: PHASE1, PHASE2 • Sponsor: University of Oxford • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 26, 2026 12:32 UTC
-
Chatbot boosts mental health for refugee parents in jordan
Disease control CompletedThis study tested a chatbot called ParentText for Crisis, designed to support Palestinian caregivers living in a refugee camp in Jordan. The goal was to see if the chatbot could improve caregivers' mental health, encourage positive parenting, and reduce violence against children.…
Phase: NA • Sponsor: University of Oxford • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Malaria vaccine trial targets kids with HIV
Disease control CompletedThis study tested the safety and immune response of the R21/Matrix-M malaria vaccine in 122 African children aged 5-36 months, some living with HIV and some without. The goal was to see if the vaccine is safe and produces an immune response in these children. The trial has been c…
Phase: PHASE1 • Sponsor: University of Oxford • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Old malaria drug could boost lung cancer treatment
Disease control CompletedThis early-phase trial tested adding the anti-parasitic drug atovaquone to standard chemotherapy and radiation for people with locally advanced non-small cell lung cancer. The main goal was to find the safest dose of atovaquone in this combination. Twenty-one participants receive…
Phase: PHASE1 • Sponsor: University of Oxford • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Can a Low-Carb app help control diabetes?
Disease control CompletedThis study tested whether a 12-week low-carbohydrate diet program, delivered through a smartphone app with remote coaching, could help people with type 2 diabetes improve their blood sugar and lose weight. 115 adults recently diagnosed with type 2 diabetes and who were overweight…
Phase: NA • Sponsor: University of Oxford • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Could a common parasite drug help young kids with scabies?
Disease control CompletedThis study tested the safety and effectiveness of oral ivermectin for treating scabies in children weighing 5 to less than 15 kilograms. 240 children participated, receiving either ivermectin, a standard permethrin cream, or a placebo. The goal is to see if ivermectin can be a sa…
Phase: PHASE2 • Sponsor: University of Oxford • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New ivermectin minitablets could treat scabies in infants and toddlers
Disease control CompletedThis completed Phase 2 trial tested oral ivermectin minitablets in 13 children aged 3 months and older weighing 5 to less than 15 kilograms who had scabies. The study aimed to check the safety, how the drug works in the body, and how well it treats the infection. Results will hel…
Phase: PHASE2 • Sponsor: University of Oxford • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Study tests if starting stronger drugs earlier tames psoriatic arthritis
Disease control CompletedThis completed trial tested whether starting stronger medications early helps people with moderate to severe psoriatic arthritis more than the usual step-up approach. 192 adults were randomly assigned to standard care, early combination disease-modifying drugs, or early TNF inhib…
Phase: PHASE4 • Sponsor: University of Oxford • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Could a viagra drug shield the brain from stroke damage?
Disease control CompletedThis study tested whether sildenafil, a drug used for erectile dysfunction, can reduce harmful pulsations in brain blood flow in 75 people who had a stroke or mini-stroke due to small vessel disease. Participants took sildenafil, a similar drug (cilostazol), or a placebo for thre…
Phase: PHASE2 • Sponsor: University of Oxford • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Triple threat: new malaria cocktail aims to outsmart resistance
Disease control CompletedThis large Phase 3 trial tested whether combining three antimalarial drugs works better than the standard two-drug treatments for uncomplicated malaria in African children. Over 2,500 children aged 6 months to 12 years received either a triple or standard therapy. The goal was to…
Phase: PHASE3 • Sponsor: University of Oxford • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Brain pacemaker that adapts to you: hope for rare Parkinson's-Like disease
Disease control CompletedThis small study tested a new type of deep brain stimulation (DBS) that automatically adjusts electrical pulses based on a person's activity or body position. The goal was to improve walking, blood pressure, bladder control, and sleep in people with Multiple System Atrophy (MSA),…
Phase: NA • Sponsor: University of Oxford • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New test could speed up scrub typhus diagnosis
Diagnosis CompletedThis study tested a new molecular test (iiPCR) to diagnose scrub typhus, a bacterial infection spread by mites. Researchers compared the test's accuracy against standard methods in 345 participants in Thailand. The goal was to see if this tool could provide faster, reliable diagn…
Sponsor: University of Oxford • Aim: Diagnosis
Last updated Jun 27, 2026 12:28 UTC
-
New 'Star Homes' aim to slash childhood disease in tanzania
Prevention CompletedThis study tested whether specially built houses (Star Homes) could reduce malaria, respiratory infections, and diarrhea in children under 13 in rural Tanzania. Over 1,100 children lived either in a Star Home or a traditional mud house. The Star Homes have screened windows, solar…
Phase: NA • Sponsor: University of Oxford • Aim: Prevention
Last updated Jun 27, 2026 12:29 UTC
-
Sleep app shows promise for fibromyalgia sufferers
Symptom relief CompletedThis study tested whether a digital sleep therapy program called Sleepio can improve quality of life, sleep, and thinking in people with fibromyalgia. 80 participants were randomly assigned to use Sleepio or receive standard sleep advice. Researchers measured changes in symptoms …
Phase: NA • Sponsor: University of Oxford • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Weight loss programme may ease heart symptoms in seniors with AF
Symptom relief CompletedThis study tested whether a commercial meal replacement weight loss programme could reduce atrial fibrillation (AF) symptoms in overweight adults aged 60-85 with persistent AF. 119 participants were randomly assigned to either the weight loss programme or usual care for 32-36 wee…
Phase: NA • Sponsor: University of Oxford • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Sleepio shows promise for Post-Stroke insomnia in small trial
Symptom relief CompletedThis study tested whether an online cognitive behavioural therapy program called Sleepio could improve sleep in people who have had a stroke. 86 chronic stroke survivors were randomly assigned to either use Sleepio for 6 weeks or receive a leaflet with basic sleep tips. The main …
Phase: NA • Sponsor: University of Oxford • Aim: Symptom relief
Last updated Jun 26, 2026 15:53 UTC
-
Real-World study tests whether aggressive early treatment improves psoriatic arthritis outcomes
Knowledge-focused CompletedThis study follows people newly diagnosed with psoriatic arthritis (PsA) to see how a 'treat to target' approach works in everyday clinics. Participants receive standard care, often starting with methotrexate, and their disease activity is tracked over time. The goal is to unders…
Sponsor: University of Oxford • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Oxford scientists probe why nerve exercises ease carpal tunnel pain
Knowledge-focused CompletedThis study from the University of Oxford aims to understand how specific physiotherapy exercises (neurodynamic exercises) work for carpal tunnel syndrome. Researchers will compare these exercises to standard steroid injections and simple advice in 78 patients with mild to moderat…
Phase: NA • Sponsor: University of Oxford • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Chatbot and teacher team up to boost parenting in malaysia
Knowledge-focused CompletedThis study tested a program called Naungan Kasih-Hybrid that combines a single in-person session, teacher-led WhatsApp groups, and a chatbot to help parents of preschoolers in low-income families in Malaysia. Over 770 parents and 750 children from 50 preschools took part. The goa…
Phase: NA • Sponsor: University of Oxford • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Can a chatbot help parents play and learn with their kids? malaysia study says maybe
Knowledge-focused CompletedThis study tested a parenting program called Naungan Kasih that uses a chatbot, in-person teacher sessions, and WhatsApp groups to help parents of 4-6 year olds in Malaysia play and learn with their children. 208 parents took part to see which combination of tools worked best. Th…
Phase: NA • Sponsor: University of Oxford • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
Ketone drink study reveals surprising effects on blood sugar and liver fat
Knowledge-focused CompletedThis study looked at how a ketone drink changes blood sugar and liver fat production in 12 healthy adults, comparing when they were fasted versus after a meal. Researchers wanted to understand if the drink's effects differ based on whether you've just eaten. The goal is to learn …
Phase: NA • Sponsor: University of Oxford • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Scientists probe how meningitis vaccines spark immunity
Knowledge-focused CompletedThis study looked at how different meningococcal vaccines affect B cells, the white blood cells that produce antibodies. Researchers gave 20 healthy adults aged 30-70 either a polysaccharide or conjugate vaccine and then measured their B cell responses. The goal was to understand…
Phase: PHASE4 • Sponsor: University of Oxford • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Iron pills may boost vaccine power in pregnancy, study hints
Knowledge-focused CompletedThis study looked at whether iron supplements improve how well vaccines work in pregnant women with anemia (low iron). Researchers compared their immune responses to tetanus, diphtheria, and COVID-19 vaccines against women without anemia. The goal was to see if correcting iron de…
Phase: NA • Sponsor: University of Oxford • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Peer support groups tested to help War-Torn families
Knowledge-focused CompletedThis study tested whether 'Hope Groups'—peer-led support groups for Ukrainian caregivers affected by war—can improve mental health and reduce violence against children. Over 500 caregivers participated, with some receiving the 12-session program and others on a waitlist. The goal…
Phase: NA • Sponsor: University of Oxford • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Smart wearables could alert nurses to patient danger sooner
Knowledge-focused CompletedThis study tested a wearable monitoring system that tracks vital signs like heart rate and breathing continuously. The goal was to see if it helps hospital staff detect when surgical patients are getting worse faster than standard checks. 240 adults on a surgical ward took part, …
Phase: NA • Sponsor: University of Oxford • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
New digital platform aims to speed up bleeding research recruitment
Knowledge-focused CompletedThis study tested a digital platform that helps hospital staff quickly identify patients who are bleeding, so they can be asked to join future research studies. About 40 adults admitted to Oxford University Hospitals took part. The goal was to see if the platform could correctly …
Sponsor: University of Oxford • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
Oxford researchers seek better way to open collapsed lungs in ICU
Knowledge-focused CompletedThis University of Oxford study looked at 48 ICU patients on ventilators for respiratory failure. Doctors sometimes inflate the lungs briefly (a recruitment manoeuvre) to reopen collapsed areas, but it's unclear when this helps. Researchers used a device to measure lung volume an…
Sponsor: University of Oxford • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
New study uses family interviews to uncover why people die in remote asian villages
Knowledge-focused CompletedThis study interviewed family members of over 3,400 people who died in rural villages in Bangladesh, Laos, Thailand, Cambodia, and Myanmar. The goal was to figure out the causes of death in areas where official records are poor. Researchers used a standard questionnaire called ve…
Sponsor: University of Oxford • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Can a village health program cut newborn deaths? large trial in cambodia seeks answers
Knowledge-focused CompletedThis study tested a comprehensive neonatal healthcare package called the Saving Babies' Lives Programme in rural Cambodia. Over 24,000 participants were involved across villages and hospitals. The goal was to see if training healthcare workers and supporting community volunteers …
Phase: NA • Sponsor: University of Oxford • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Scientists study mosquito saliva to predict malaria and dengue risk
Knowledge-focused CompletedThis study looked at how people's immune systems react to proteins in mosquito saliva after being bitten. Researchers exposed 147 healthy adults in Thailand to lab-grown mosquitoes that can carry malaria or dengue. The goal was to find markers in the blood that show how much expo…
Phase: NA • Sponsor: University of Oxford • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
Sepsis study aims to sharpen diagnosis in thailand
Knowledge-focused CompletedThis completed study in Thailand looked at how well the latest sepsis definition (Sepsis-3) works for patients with community-acquired sepsis. Researchers collected blood and other samples from 1002 adults at a hospital in Ubon Ratchathani. They tracked who survived for 28 days a…
Sponsor: University of Oxford • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC
-
UK study tests newborn screening for rare muscle disease
Knowledge-focused CompletedThis completed study looked at whether it is practical and acceptable to screen all newborns for spinal muscular atrophy (SMA), a rare genetic disease that causes muscle weakness and can be fatal if not treated early. Over 33,000 babies were screened using a simple blood spot tes…
Sponsor: University of Oxford • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC